Webinar

P.A.C.E. CE: Differentiation of HSV and VZV Lesions Using Multiplex Molecular Testing

May 6, 2024
main-image

Duration: 1 hour

During this live one-hour P.A.C.E.®-accredited webinar hosted by Fisher Healthcare and sponsored by QuidelOrtho, join Preeti Pancholi, PhD, Professor and Director of the Clinical Microbiology Laboratory at The Ohio State University Wexner Medical Center to explore virus diagnostics and testing of HSV and VZV.

Herpes simplex viruses (HSV-1; HSV-2) and the varicella zoster virus (VZV) are some of the most common causes of primary and latent oral, genital and cutaneous lesions. Over 66 percent of individuals under 50 have HSV-1, while HSV-2 is one of the most common sexually transmitted infections. Up to 95 percent of the current world population may also be infected with latent VZV, which can result in herpes zoster (shingles) later in life.

While primary antiviral treatment of HSV and VZV are often the same, the need for and duration of treatment and recurrence prevention differ, as does the rate of recurrence, transmissibility and long-term complications. Therefore, it is imperative that lesions be diagnosed accurately.

This webinar will discuss the prevalence of herpes virus-related lesions and the importance of viral differentiation, evaluate diagnostic challenges and provide information on using rapid near-patient multiplex molecular testing to improve lesion diagnosis.

This webinar will help you:
 

  • Review the prevalence of herpes virus-related lesions
  • Discuss the clinical importance of differentiating HSV-1, HSV-2 and VZV
  • Explain the diagnostic challenges associated with herpes virus lesions and how a molecular multiplex assay can improve diagnostic accuracy
  • Identify how rapid near-patient molecular testing can improve workflow and patient outcomes
Register now

Disclosures: This promotional educational activity is brought to you by  QuidelOrtho. The speakers are presenting on behalf of QuidelOrtho and must present information in accordance with applicable and/or local regulatory country requirements. Fisher Healthcare is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.